Archive
SCIENTIFIC WORK - 2026 SCIENTIFIC WORK - 2025 SCIENTIFIC WORK - 2024 SCIENTIFIC WORK - 2023 SCIENTIFIC WORK - 2022 SCIENTIFIC WORK - 2021 SCIENTIFIC WORK - 2020 SCIENTIFIC WORK - 2019 SCIENTIFIC WORK - 2018 SCIENTIFIC WORK - 2017 SCIENTIFIC WORK - 2016 SCIENTIFIC WORK - 2015 SCIENTIFIC WORK - 2014 SCIENTIFIC WORK - 2013 SCIENTIFIC WORK - 2012 SCIENTIFIC WORK - 2011 SCIENTIFIC WORK - 2010 SCIENTIFIC WORK - 2009 SCIENTIFIC WORK - 2008 SCIENTIFIC WORK - 2007

DOI:  https://doi.org/10.36719/2663-4619/115/258-264

Malahat Baghirova

Azerbaijan Medical University

https://orcid.org/0009-0000-2969-0082

bmelahet@gmail.com

Konul Jafarova

Azerbaijan Medical University

https://orcid.org/0000-0002-1109-1548

PhD in Medicine

infeksiyakonul@gmail.com

Rana Nazarova

Azerbaijan Medical University

https://orcid.org/0009-0004-5167-7107

shah241962@yahoo.com

Gulnara Karimova

Azerbaijan Medical University

https://orcid.org/0009-0000-3912-4260

gulnara@gmail.com

Museyib Abdullayev

Azerbaijan Medical University

https://orcid.org/0009-0001-9931-4573

abdullayevmuseyib763@gmail.com

 

The Whooping Cough Epidemic in the Post-Covid Period

and Ways to Prevent It

 

Abstract

 

Pertussis is currently considered one of the most common, controlled infections worldwide. In the pre - vaccination period, pertussis was one of the main causes of child mortality, but the introduction of planned immunization has led to a sharp decrease in morbidity and mortality. Despite the official registration of planned immunoprophylaxis of a large mass of the population (up to 97 %), until now cyclical ups and downs of pertussis occur with a cycle of 3 - 4 years. According to the CDC, only 5 - 10 % of all pertussis cases are diagnosed and recorded.

Mass vaccination had a serious effect on the epidemiological characteristics of pertussis, but it was not possible to achieve complete elimination of the causative agent. Currently, there is an increase in the incidence of pertussis, mainly in countries that use acellular vaccines for vaccination. During the year, 16 million people in the world get sick with pertussis, and 19,500 people die. In developing countries, especially in Africa, the mortality rate of early-age children from pertussis is 23%. Even in developed countries that use acellular vaccines, the incidence of pertussis has increased. So, acellular vaccine is used in more than 50 countries of the world. The result of the conducted studies show that those who received 5 doses of acellular vaccine have an 8.57 and 3.55 times higher risk of contracting pertussis compared to cellular vaccines (at last once). Even in those who received a full course of Tdap consisting of whole-cell vaccines and one revaccination, postvaccinal immunity declines 50% or more after 6.

During the COVID-19 pandemic, the incidence of pertussis in Europe and the United States decreased, but in the period after that, an increase was observed again. In 2024 an epidemic of pertussis occurred in many countries of the world, and this is considered the most serious epidemic of the last 25 years.

Keywords: whooping cough, children, epidemic, vaccination, postvaccinal, immunity

 


Views: 498